Table 2 |
||
|
Assessment of beta-blockers used by patients (N = 72) |
||
| n (% patients) |
||
|
|
||
| Beta-blocker route |
||
|
|
||
| Oral |
70 (97) |
|
|
|
||
| Ocular |
2 (3) |
|
|
|
||
| Beta-blocker name |
||
|
|
||
| Atenolol |
42 (58) |
|
|
|
||
| Metoprolol |
15 (21) |
|
|
|
||
| Nadolol |
4 (6) |
|
|
|
||
| Acebutalol |
4 (6) |
|
|
|
||
| Propanolol |
2 (3) |
|
|
|
||
| Bisprolol |
2 (3) |
|
|
|
||
| Timolol |
1 (1) |
|
|
|
||
| Labetolol |
1 (1) |
|
|
|
||
|
Fung and Kim Allergy, Asthma & Clinical Immunology 2010 6:2 doi:10.1186/1710-1492-6-2 |
||
